COVID-19 one year later: Ethical issues in human subjects eye research when responding to a crisis

Free webinar: Sept. 22 | 8:30 - 9:45am ET
Hosted by the Ethics and Regulations in Human Research Committee (ERHR)

The coronavirus SARS-COV-2 and its associated disease, COVID-19, have had profound global effects on the ability to continue scientific research involving human subjects. Investigators leading and participating in these studies need to manage new ethical, health and safety issues in the presence of this highly infectious and potentially fatal disease. Additionally, investigators must account for this major confounding factor when analyzing the research data. 

This webinar will explore:

  • Varying responses to SARS-COV-2/COVID- 19 across the globe, and their impacts on the conduct of human research
  • The ethical and safety issues specific to vision research and COVID-19
  • How a major interruption or shutdown may impact experimental design and data analysis.

Audience: All researchers conducting human research studies.

This webinar is hosted by the Ethics and Regulations in Human Research Committee and provided at no charge. A Certificate of Attendance is available to attendees. 

register today button 



Lyndell Lim

Lyndell Lim, MBBS, DMedSci, Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Victoria, Australia

Sangita PatelSangita P. Patel, MD, PhD, Department of Ophthalmology, University at Buffalo, Buffalo, New York; Ophthalmology and Research Services, Veterans Health Administration, Western New York Health Care System, Buffalo, New York

Russell WoodsRussell Woods, PhD, Associate Scientist, Schepens Eye Research Institute; Associate Professor of Ophthalmology, Harvard Medical School


Jane WilliamsGlobal responses to COVID-19 and their impact on life and human research
Jane Williams, MPH, PhD, Postdoctoral Research Fellow, Sydney Health Ethics, The University of Sydney  

Melissa LiewClinical trial issues specific to vision research and COVID-19
Melissa Liew, MD MRCOphth, Global Translational Medicine Head, Ophthalmology, Novartis Institutes for BioMedical Research 

The IRB perspective on wide-spread study shutdown
Martha F. Jones, MA, CIP, Vice President, Human Research Affairs, Mass General Brigham

Traci Clemons

Statistical considerations around analysis of disrupted studies and potential confounding from COVID-19
Traci Clemons, Senior Biostatistician and Project Leader, The Emmes Company, LLC